CHI3L1 and experimental autoimmune encephalomyelitis: YKL-40 has been reported to be neuroprotective and/or anti-inflammatory in traumatic brain injury [38], experimental autoimmune encephalomyelitis [39], and bacterial infection [40]; whereas others have observed attenuated cell viability and retracted neurites in primary cortical neurons treated with YKL-40 [41, 42].